1036 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
4 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
5 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
8 Not yet recruiting Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Carcinoma
Intervention:
9 Not yet recruiting A Study of Atezolizumab (MPDL3280A) as First-line Monotherapy for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC): Clinical Evaluation of Novel Blood-Based Diagnostics
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Atezolizumab
10 Recruiting A Positron Emission Tomography (PET) Imaging Agent [18F]-ODS2004436 as a Marker of EGFR Mutation in Subjects With NSCLC
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Other: Injection of [18F]-ODS2004436 radiotracer
11 Not yet recruiting Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Drug: Plinabulin
12 Recruiting Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung Cancer
Condition: Recurrent Non-small Cell Lung Cancer
Interventions: Drug: Cetuximab;   Biological: NK immunotherapy
13 Not yet recruiting DE-CT in Lung Cancer Proton Therapy
Condition: Non Small Cell Lung Cancer
Intervention: Procedure: DE-CT's and 4D-CT
14 Recruiting Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Ganoderma lucidum spore;   Drug: Placebo;   Drug: Chemotherapy
15 Recruiting Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic
Interventions: Device: Cryosurgery;   Biological: NK Immunotherapy
16 Not yet recruiting Improving Pulmonary Function Following Radiation Therapy
Condition: Non-Small Cell Lung Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Radiation: Standard fractionation;   Radiation: Stereotactic Body Radiation Therapy (SBRT);   Procedure: Four Dimensional Computed Tomographic Imaging (4DCT)
17 Not yet recruiting Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Osimertinib
18 Recruiting Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Radiation: IMRT + SIB + Chemotherapy
19 Not yet recruiting A Trial of CV301 in Combination With Nivolumab Versus Nivolumab in Subjects With Previously Treated Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer (NSCLC)
Interventions: Biological: CV301;   Biological: nivolumab
20 Recruiting The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections
Condition: Non-small Cell Lung Cancer
Interventions: Drug: General anesthesia;   Drug: Combined general/epidural anesthesia

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years